Dysfunction of the microRNA (miR) network has been emerging as a major regulator in neurological diseases. However, little is known about the functional significance of unique miRs in ischemic brain damage. Here, we found that miR-497 is induced in mouse brain after transient middle cerebral artery occlusion (MCAO) and mouse N2A neuroblastoma (N2A) cells after oxygen-glucose deprivation (OGD). Loss-of-miR-497 function significantly suppresses OGD-induced N2A cell death, whereas gain-of-miR-497 function aggravates OGD-induced neuronal loss. Moreover, miR-497 directly binds to the predicted 3′-UTR target sites of bcl-2/-w genes. Furthermore, knockdown of cerebral miR-497 effectively enhances bcl-2/-w protein levels in the ischemic region, attenuates ischemic brain infarction, and improves neurological outcomes in mice after focal cerebral ischemia. Taken together, our data suggest that miR-497 promotes ischemic neuronal death by negatively regulating antiapoptotic proteins, bcl-2 and bcl-w. We raise the possibility that this pathway may contribute to the pathogenesis of the ischemic brain injury in stroke.
Introduction
Ischemic stroke results from a transient or permanent local reduction of cerebral blood flow, characterized by a set of cellular disturbances. With a mortality rate of 30%, stroke is the third leading cause of death and adult disability in the United States (Goldstein et al., 2001; Kalache and Aboderin, 1995) . Unfortunately, development of effective therapies in the clinical setting is seriously limited by the rapid development of brain injury following ischemia (Schellinger et al., 2004; Stapf and Mohr, 2002) . Extensive research has demonstrated that stroke triggers complex cellular biochemical events that eventually lead to apoptotic and necrotic neuronal death in the ischemic regions (Love, 2003; Yuan, 2009 ). However, the delicate mechanisms of stroke-induced neuronal death and neurological dysfunction are not completely understood. Undoubtedly, the elucidation of molecular mechanisms of cell death will provide new insights into the understanding of cerebral protection aimed at developing neuroprotective agents for stroke therapeutics.
MicroRNAs (miRs) have been recently discovered as a novel family of non-protein coding short RNA molecules that negatively modulate protein expression in various organisms (Bartel, 2009; Bartel and Chen, 2004; Kim, 2005) . MiRs hybridize to partially complementary binding sequences that are typically localized in the 3′ untranslated regions (3′UTR) of target mRNAs, resulting in either cleavage or translational repression in a sequence-specific manner (Bartel and Chen, 2004) . It is now evident that miRs are able to regulate expression of at least one-third of the human genome and play a critical role in a variety of normal biological processes, including cell differentiation, apoptosis, development, and metabolism (Bartel, 2004; Ketting et al., 2001; Lee et al., 2004; Wienholds and Plasterk, 2005) . Furthermore, miRs are abundantly expressed in the nervous system and have been initially identified as critical mediators in the regulation of neural development and plasticity (Kosik, 2006) .
In addition, miRs have also been implicated in the etiology of a variety of human diseases, including cancer, metabolic diseases, cardiovascular diseases, and viral infections (Care et al., 2007; Krutzfeldt and Stoffel, 2006; Sullivan and Ganem, 2005; Wiemer, 2007) . Accumulating evidence has linked dysregulated cerebral miR expression to a variety of neurodegenerative diseases, including Alzheimer's disease (Hebert et al., 2008 ), Parkinson's disease (Kim et al., 2007) , and stroke (Dharap et al., 2009; Jeyaseelan et al., 2007) .
Recently, a few groups have shown the involvement of miRs in the pathogenesis of ischemic brain injury by using miR profiling techniques in a rat middle cerebral artery occlusion (MCAO) model (Dharap et al., 2009; Jeyaseelan et al., 2007) . These findings suggest several miRs as potential candidates for possible biomarkers or therapeutic targets in stroke. However, there are no studies available to date that investigate the functional significance and molecular mechanisms of individual microRNAs in post-ischemic neuronal death. In this article, we have first identified cerebral miR-497 as a critical player in the regulation of ischemic neuronal death in N2A neuroblastoma cells and also in a mouse MCAO model. We have Neurobiology of Disease 38 (2010) 17-26 
